| |
Radiation Medicine Centre
Gets First Medical Cyclotron with PET-Advance Scanner in India

Radiation Medicine Centre
(RMC), a part of Bhabha Atomic Energy Research Centre, India is situated
at Tata Memorial Hospital. They are the pioneering Institution in the
country where many Doctors and Technicians are trained in Nuclear Medicine.
They have several Gamma Cameras installed in their Hospital and also have
inpatient facility for treatment of thyroid cancer. They are also a Teaching
Hospital. In addition, they get Nuclear Medicine Physicians / Technicians
from other countries as Delegates for Training / Conferences etc.
Now RMC has decided to
purchase GE Cyclotron with PET-Advance (Positron Emission Tomography)
Scanner for the diagnosis of various diseases.
A |
B |
C |
D |
| Cerebral
sarcoidosis. Contrast - enhanced T1-weighted (A) and T2-weighted (B)
axial MR images show an enhancing lesion in the left temporal lobe
with marked edema. This lesion was initially believed to be a glioma.
On axial (C) and coronal (D) [ 18 F] FDG PET images, the lesion displays
high tracer uptake, which therefore was interpreted as a high grade
tumour. |
A | B |
| Metastasis
of follicular thyroid carcinoma. A: T2 - weighted axial MR image demonstrates
a left frontal mass lesion. B: [ 18 F] FDG PET shows the lesion to
be partly ametabolic, with the medical rim of the tumour displaying
intermediate tracer uptake. The lesion was histologically proven to
be metastatic. |
This will be India™s
first PET Scanner for India for medical diagnostic investigations.
Dr. (Mrs.) A. M. Samuel,
Director, Biomedical Group said ia For the first time in India, patients
and doctors will have access to a complete high quality detecting PET
system with applications in Oncology, Cardiology, Neurology and Psychiatry.
™™ She added id Using the cancer detecting PET technology, doctors will
be equipped with more detailed information to detect early and pinpoint
disease in the body, and thereby help provide significantly better patient
care.lp
A
 | B

Surgically proven
knee metastsis of malignant melanoma in a 39 year old woman. A: [
18 F] FDG PET scans show a lesion with markedly increased tracer uptake
in the lateral aspect of the left knee. There is an injection artefact
in the left lower arm . B: Corresponding MR image of the left knee
demonstrates a metastasis in the left lateral femoral condyle. |
|
|
|